Psoriatic Arthritis Drug Market to See Significant Increase in Sales in 7MM, Says GlobalData in Its Report Available at MarketPublishers.com14 Mar 2017 • by Natalie Aster
LONDON – A chronic immune-mediated arthritis which typically effects large joints, psoriatic arthritis (aka PsA) most commonly hits men and women aged between 30 and 50.
Though early diagnosis and intervention play a great role in the prevention of irreversible joint damage, there are many PsA patients, who are undiagnosed and do not receive treatment over months or even years.
The PsA marketplace across 7MM is forecast to showcase significant growth in the upcoming years, with its CAGR being approximately 11%. Sales which stood at slightly over USD 4.5 billion in 2015 are set to almost hit the USD 13 billion mark by 2026.
This considerable growth will ne ignited by the rise in diagnosed prevalent cases (from more than 1 million in 2015 to over 1.5 million in 2025). The upcoming expansion of the treatment armamentarium for PsA will also encourage the growth.
Today’s PsA marketplace is highly dynamic, and this can be partially attributed to the recently approved effective biologic therapies.
In-demand research report “PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025” worked out by GlobalData offers a comprehensive guide to the PsA marketplace across 7MM. The study starts with an all-round overview of the disease. It proceeds with an in-depth insight into the epidemiology.
The report comprises a detailed overview of the diagnosis and treatment. The research study covers major markets (e.g. the US and Japan). It explores the competitive landscape and contains product profiles.
The research report discusses unmet needs and opportunities. The study comprises the pipeline assessment, too. It sheds light on both current and future players: Amgen, Alder, Pfizer, Novartis, and more. The report covers drivers and barriers of the markets, limelights key events and contains forecasts.
More cutting-edge reports by GlobalData can be found at its page.